| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/02/2011 | EP2279197A1 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring |
| 02/02/2011 | EP2279196A2 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/02/2011 | EP2279184A1 Indole modulators of the alpha-7 nicotinic acetylcholine receptor |
| 02/02/2011 | EP2279183A1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 |
| 02/02/2011 | EP2279180A1 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZOÝd¨ISOXAZOL-4-ONE |
| 02/02/2011 | EP2279030A2 Method of modulating t cell-dependent immune responses |
| 02/02/2011 | EP2278987A2 Modulation and repletion/enhancement of the complement system for treatment of trauma |
| 02/02/2011 | EP2278982A2 Compositions and methods for treating neurodegenerative diseases |
| 02/02/2011 | EP2278981A2 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use |
| 02/02/2011 | EP2278980A2 Treatment of migraines without aura in pregnant women by inhalation of dioxygen gas |
| 02/02/2011 | EP2278972A1 Treatment for neurological and mental disorders |
| 02/02/2011 | EP2278967A1 Bis-quaternary pyridinium-aldoyime salts and treatment of exposure to cholinesterase inhibitors |
| 02/02/2011 | EP2278878A1 2-aryl glycinamide derivatives |
| 02/02/2011 | EP1805222B1 Antibodies directed to the mammalian eag1 ion channel protein |
| 02/02/2011 | EP1539976B1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN1942191B Pharmaceutical composition comprising a salt of mirtazapine |
| 02/02/2011 | CN1853619B Use of agomelatin in the preparation of a medicament for the treatment of bipolar disorders |
| 02/02/2011 | CN101965365A Antibody capable of combining the soluble ass oligomer specifically and application thereof |
| 02/02/2011 | CN101965344A Isoxazole-imidazole derivatives |
| 02/02/2011 | CN101965343A 2-aza-bicyclo[2.2.1]heptane derivatives |
| 02/02/2011 | CN101965339A Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 02/02/2011 | CN101965328A Process to pregabalin |
| 02/02/2011 | CN101965197A Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzeimer's disease |
| 02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
| 02/02/2011 | CN101965187A Crystalline micropowder particles |
| 02/02/2011 | CN101962384A Chromene compounds, a process for their preparation and pharmaceutical compositions containing them |
| 02/02/2011 | CN101962369A Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 02/02/2011 | CN101962365A Aminoindazole derivatives as protein-kinase inhibitors |
| 02/02/2011 | CN101962355A New piperidine compounds, their preparation process and the pharmaceutical compositions containing these compounds |
| 02/02/2011 | CN101961489A Method for establishing experimental model for subclinical hepatic encephalopathy (SHE) |
| 02/02/2011 | CN101961483A Application of intramembrane segment of amyloid protein to preparing drug for treating Alzheimer's disease |
| 02/02/2011 | CN101961436A Bath effervescent tablets for improving sleep |
| 02/02/2011 | CN101961418A Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch |
| 02/02/2011 | CN101961400A Chinese medicament for treating sciatica and preparation method and application thereof |
| 02/02/2011 | CN101961389A Scorpion pain-relieving powder medicine |
| 02/02/2011 | CN101961381A Preparation method of particles in formula of salvia miltiorrhiza bunge and quality detection method thereof |
| 02/02/2011 | CN101961365A Use of silymarin and silybin in the treatment of neural injury |
| 02/02/2011 | CN101961363A Preparation method of active pseudo-ginseng slices |
| 02/02/2011 | CN101961362A Method for preparing active pseudo-ginseng granule |
| 02/02/2011 | CN101961361A Method for preparing active pseudo-ginseng |
| 02/02/2011 | CN101961358A Preparation method of hypericum perforatum extractive |
| 02/02/2011 | CN101961350A Preparation method of fishy smell-removed pearl powder |
| 02/02/2011 | CN101961326A Application of physcion in preparing medicines for treating depression |
| 02/02/2011 | CN101961325A Application of emodin in preparation of drugs for treating depression |
| 02/02/2011 | CN101961315A Ornithine aspartate liposome injection |
| 02/02/2011 | CN101961312A Lipoid acid composition for injection |
| 02/02/2011 | CN101961311A 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method thereof |
| 02/02/2011 | CN101961192A Chinese medicinal health-care pillow |
| 02/02/2011 | CN101961190A Drug pillow for insomnia recovery |
| 02/02/2011 | CN101961189A Health pillow |
| 02/02/2011 | CN101961178A Healthy back cushion |
| 02/02/2011 | CN101475576B Flavone lignose compound, and preparation and pharmaceutical use thereof |
| 02/02/2011 | CN101352530B Medicine for treating epilepsy |
| 02/02/2011 | CN101352502B Plaster for curing facial paralysis and method of preparing the same |
| 02/02/2011 | CN101326945B Jujube chestnut leaf tea |
| 02/02/2011 | CN101229349B Medicine for treating senile dementia and preparing method thereof |
| 02/02/2011 | CN101137657B Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists |
| 02/02/2011 | CN101002836B Use of the extractive of radix cynanchi bungei total glucoside |
| 02/01/2011 | USRE42096 FDA Orange book listed patent for amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate; sustained release for improved patient compliance, fewer dosages needed; attention deficit |
| 02/01/2011 | US7880009 Cinnamide compound |
| 02/01/2011 | US7880008 Heterocycles useful as modulators of ion channels |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879889 Therapeutic use of acylaminothiazole derivatives |
| 02/01/2011 | US7879882 Thiazolyl mglur5 antagonists and methods for their use |
| 02/01/2011 | US7879865 central nervous system disorders; brain cancer; oral administration |
| 02/01/2011 | US7879857 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors |
| 02/01/2011 | US7879844 Heterocyclic janus kinase 3 inhibitors |
| 02/01/2011 | US7879826 N-methyl-D-aspartate (NMDA) receptor antagonists, such as Diethyl 3,3'-[({2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethyl}phosphoryl)bis(oxy)]dibenzoate, used for treating pain in a mammals; analgesics |
| 02/01/2011 | US7879825 N-methyl-D-aspartate (NMDA) receptor antagonists, such as 3-{2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethyl)-3-oxido-7-oxo-7-phenyl-2,4,6-trioxa-3-phosphahept-1-yl benzoate, used for treating pain ; analgesics |
| 02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879359 Compositions for preparing external carbon dioxide agents |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2688915C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/01/2011 | CA2630040C Heterocycle-substituted 3-alkyl azetidine derivatives |
| 02/01/2011 | CA2494091C Substituted furo [2,3-b| pyridine derivatives |
| 02/01/2011 | CA2488220C Medicament with delayed active constituent release containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol |
| 02/01/2011 | CA2484935C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 02/01/2011 | CA2461218C Muscarinic agonists |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2446812C Novel sulfonate-substituted pyrazolopyridine derivatives |
| 02/01/2011 | CA2425172C Methods of decreasing or preventing pain using spicamycin derivatives |
| 02/01/2011 | CA2406212C Substituted styryl benzylsulfones for treating proliferative disorders |
| 02/01/2011 | CA2405508C Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 02/01/2011 | CA2403424C Flavone derivatives, preparation method and use as medicines |
| 02/01/2011 | CA2388377C Medication for the treatment of chronic fatigue syndrome and related symptoms |
| 02/01/2011 | CA2388369C Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 02/01/2011 | CA2380857C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/01/2011 | CA2320116C 2-aminoquinoline derivatives having d4-agonistic activity |
| 01/27/2011 | WO2011011766A1 Galantamine amino acid and peptide prodrugs and uses thereof |
| 01/27/2011 | WO2011011721A2 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
| 01/27/2011 | WO2011011692A2 Methods of treating and preventing/reducing the likelihood of mesial temporal lobe epilepsy (tle) |
| 01/27/2011 | WO2011011594A2 Intracellular toll-like receptors pathways and axonal degeneration |